These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15650911)

  • 1. [Report on Notifications pursuant to Section 21 German Transfusion Act for 2001 and 2002].
    Haschberger B; Waterkamp A; Heiden M; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Jan; 48(1):99-119. PubMed ID: 15650911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Report on notifications pursuant to Section 21 German Transfusion Act for 2007].
    Henseler O; Heiden M; Haschberger B; Hesse J; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jul; 52(7):715-31. PubMed ID: 19572110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Report on notifications pursuant to Section 21 German Transfusion Act for 2005 and 2006].
    Haschberger B; Henseler O; Hesse J; Heiden M; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Mar; 51(3):353-72. PubMed ID: 18369571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Report on notifications pursuant to Section 21 of the German Transfusion Act for the years 2008 and 2009].
    Henseler O; Heiden M; Haschberger B; Hesse J; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Oct; 53(10):1089-103. PubMed ID: 20936454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Report on notifications with respect to section sign 21 German Transfusion Act for 2003 and 2004].
    Waterkamp A; Haschberger B; Hesse J; Heiden M; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Feb; 50(2):209-29. PubMed ID: 17285352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Report on notifications pursuant to §21 German Transfusion Act for 2010 and 2011].
    Henseler O; Heiden M; Haschberger B; Hesse J; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Oct; 56(10):1352-67. PubMed ID: 24002586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report on Notifications Pursuant to section sign21 German Transfusion Act for 2007.
    Henseler O; Heiden M; Haschberger B; Hesse J; Seitz R
    Transfus Med Hemother; 2010 Feb; 37(1):29-47. PubMed ID: 20737014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report on Notifications Pursuant to §21 German Transfusion Act for 2008 and 2009.
    Henseler O; Heiden M; Haschberger B; Hesse J; Seitz R
    Transfus Med Hemother; 2011; 38(3):199-216. PubMed ID: 21760765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood components: indication and notice of transfusion].
    Sekiguchi S
    Nihon Rinsho; 1997 Sep; 55(9):2205-13. PubMed ID: 9301278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood collection and transfusion in the United States in 1999.
    Sullivan MT; Wallace EL
    Transfusion; 2005 Feb; 45(2):141-8. PubMed ID: 15660821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The annual cost of blood transfusions in the United Kingdom.
    Guest JF; Munro V; Cookson RF
    Clin Lab Haematol; 1998 Apr; 20(2):111-8. PubMed ID: 9681222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood collection and transfusion in the United States in 2001.
    Sullivan MT; Cotten R; Read EJ; Wallace EL
    Transfusion; 2007 Mar; 47(3):385-94. PubMed ID: 17319817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in United States blood collection and transfusion: results from the 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey.
    Whitaker B; Rajbhandary S; Kleinman S; Harris A; Kamani N
    Transfusion; 2016 Sep; 56(9):2173-83. PubMed ID: 27301995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma for fractionation in a public setting: cost analysis from the perspective of the third-party payer.
    Eandi M; Gandini G; Povero M; Zaniolo O; Pradelli L; Aprili G
    Blood Transfus; 2015 Jan; 13(1):37-45. PubMed ID: 25636129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Production and consumption of blood and blood products in Norway. Factors of quality assurance in transfusion medicine].
    Heier HE
    Tidsskr Nor Laegeforen; 1993 Jan; 113(1):18-22. PubMed ID: 8424244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood banking and transfusion medicine for the nephrologist.
    Wehrli G
    Semin Dial; 2012; 25(2):114-8. PubMed ID: 22276991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood donor-, apheresis-, and transfusion-related activities: results of the 1991 American Association of Blood Banks Institutional Membership Questionnaire.
    Devine P; Linden JV; Hoffstadter LK; Postoway N; Hines D
    Transfusion; 1993 Sep; 33(9):779-82. PubMed ID: 8212124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood collection and transfusion in the United States in 1997.
    Sullivan MT; McCullough J; Schreiber GB; Wallace EL
    Transfusion; 2002 Oct; 42(10):1253-60. PubMed ID: 12423507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collection and transfusion of blood in the United States, 1982-1988.
    Surgenor DM; Wallace EL; Hao SH; Chapman RH
    N Engl J Med; 1990 Jun; 322(23):1646-51. PubMed ID: 2342524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of red cell substitutes on the blood service in Japan.
    Sekiguchi S
    Artif Cells Blood Substit Immobil Biotechnol; 1997; 25(1-2):53-60. PubMed ID: 9083626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.